Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). H U Group Holdings's share price for the quarter that ended in Dec. 2024 was 円2559. H U Group Holdings's Shares Outstanding (EOP) for the quarter that ended in Dec. 2024 was 57 Mil. Therefore, H U Group Holdings's market cap for the quarter that ended in Dec. 2024 was 円145,397 Mil.
H U Group Holdings's quarterly market cap
increased
from Jun. 2024 (円133,468 Mil) to Sep. 2024 (円150,656 Mil) but then
declined
from Sep. 2024 (円150,656 Mil) to Dec. 2024 (円145,397 Mil).
H U Group Holdings's annual market cap
declined
from Mar. 2022 (円165,231 Mil) to Mar. 2023 (円151,725 Mil) and
declined
from Mar. 2023 (円151,725 Mil) to Mar. 2024 (円138,752 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. H U Group Holdings's Enterprise Value for Today is 円185,479 Mil.
H U Group Holdings Market Cap Historical Data
The historical data trend for H U Group Holdings's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of H U Group Holdings's Market Cap
For the Diagnostics & Research subindustry, H U Group Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
H U Group Holdings's Market Cap Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, H U Group Holdings's Market Cap distribution charts can be found below:
* The bar in red indicates where H U Group Holdings's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
H U Group Holdings's Market Cap for the fiscal year that ended in Mar. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
H U Group Holdings (TSE:4544) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
H U Group Holdings Market Cap Related Terms
Thank you for viewing the detailed overview of H U Group Holdings's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
H U Group Holdings Inc operates in the healthcare field, focusing on clinical laboratory testing and reagents. The company is engaged in four main businesses. The Clinical Laboratory Testing Business receives samples taken from patients at medical institutions to test for the disease and confirm the condition of the patient's health; In Vitro Diagnostics develops, manufactures, and sells testing reagents and equipment inside and outside Japan; Sterilization & Related Services Business provides a range of medical-related services including sterilization; and Emerging New Business & Others is a new business for future growth.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSE:4544 has been successfully added to your 